HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Gastinger, M. J. Articles by Barber, A. J. Search for Related Content PubMed PubMed Citation Articles by Gastinger, M. J. Articles by Barber, A. J.

Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2^Akita-Diabetic Mouse Retinas

From the Milton S. Hershey Medical Center, Penn State Retina Research Group, Ulrich Ophthalmology Research Laboratory, Pennsylvania State College of Medicine, Hershey, Pennsylvania.

PURPOSE. To identify amacrine cells that are vulnerable to degeneration during the early stages of diabetes.

METHODS. Whole retinas from streptozotocin (STZ)-diabetic rats and Ins2^Akita mice were fixed in paraformaldehyde. Apoptotic cells in the retina were quantified using terminal dUTP nick-end labeling (TUNEL) and active caspase-3 (CM-1) immunohistochemistry. Immunohistochemical markers for choline acetyltransferase (ChAT) and tyrosine hyroxylase (TH) were also used to quantify populations of amacrine cells in the Ins2^Akita mouse retinas.

RESULTS. The number of TUNEL-positive nuclei increased from 29 ± 4 in controls to 72 ± 9 in the STZ-diabetic rat retinas after only 2 weeks of diabetes. In rats, CM-1-immunoreactive (IR) cells were found primarily in the inner nuclear and ganglion cell layers after 2, 8, and 16 weeks of diabetes. At each end point, the number of CM-1-IR cells in the retina was elevated by diabetes. Approximately 2% to 6% of the CM-1-IR cells in the inner nuclear layer (INL) were double-labeled for TH immunoreactivity. After 6 months of diabetes in the Ins2^Akita mouse, the morphology of the labeled ChAT-IR and TH-IR amacrine cell somas and dendrites appeared normal. A quantitative analysis revealed a 20% decrease in the number of cholinergic and a 16% decrease in dopaminergic amacrine cells in the diabetic mouse retinas, compared with the nondiabetic control.

CONCLUSIONS. Dopaminergic and cholinergic amacrine cells are lost during the early stages of retinal neuropathy in diabetes. Loss of these neurons may play a critical role in the development of visual deficits in diabetes.

This article has been cited by other articles:

				H. W. van Dijk, P. H. B. Kok, M. Garvin, M. Sonka, J. H. DeVries, R. P. J. Michels, M. E. J. van Velthoven, R. O. Schlingemann, F. D. Verbraak, and M. D. Abramoff Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3404 - 3409. [Abstract] [Full Text] [PDF]

				T. S. Kern and A. J. Barber Retinal ganglion cells in diabetes J. Physiol., September 15, 2008; 586(18): 4401 - 4408. [Abstract] [Full Text] [PDF]

				K. Kohzaki, A. J. Vingrys, and B. V. Bui Early Inner Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3595 - 3604. [Abstract] [Full Text] [PDF]

				M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2Akita Diabetic Mice Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2635 - 2642. [Abstract] [Full Text] [PDF]

				E. Carrasco, C. Hernandez, A. Miralles, P. Huguet, J. Farres, and R. Simo Lower Somatostatin Expression Is an Early Event in Diabetic Retinopathy and Is Associated With Retinal Neurodegeneration Diabetes Care, November 1, 2007; 30(11): 2902 - 2908. [Abstract] [Full Text] [PDF]

				J. A. Phipps, J. L. Wilkinson-Berka, and E. L. Fletcher Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 927 - 934. [Abstract] [Full Text] [PDF]